Details of the Drug Reposition

General Information of This Drug (ID: DMTY2K8)

Drug Name
Lodoxamide   DMTY2K8
Synonyms Lodoxamide ethyl; Lodoxamide trometamol; Lodoxamide tromethamine; U-42585; U-42585E; U-42718
Drug Type
Small molecular drug
Structure
3D MOL 2D MOL

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
1 Approved Indication(s)
Indication Name Indication ID ICD-11 Status REF
Vernal keratoconjunctivitis DIS36LV6 N.A. Approved [1]
------------------------------------------------------------------------------------
1 Discontinued in Phase 2 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Vernal conjunctivitis DISSQWNO N.A. Discontinued in Phase 2 [2]
------------------------------------------------------------------------------------
1 Investigative Indication(s)
Indication Name Indication ID ICD-11 Status REF
Asthma DISW9QNS CA23 Investigative [3]
------------------------------------------------------------------------------------

References

1 Lodoxamide FDA Label
2 Trial of Outpatient Immunotherapy With Rituximab and Aldesleukin (IL-2) vs. Rituximab Alone for Non-Hodgkin's Lymphoma
3 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services. 2015